We recently showed that KLK5 exerts tumour suppressive effects by inhibiting the mevalonate pathway in breast cancer cells, thus, inhibiting the activation of signaling oncoproteins due to inhibited prenylation [11]. Here, KLK5 is linked to neoplasm.